26.11.2019 | New Publications
Two publications provide new insights.
6.8.2019 | New Partner
NMI TT Pharmaservices is proud to announce its new DigiWest® partnership with LI-COR Biosciences
21.5.2019 | New Publication
We are delighted to see that our DigiWest® data contributed to this exciting Nature Communications article
10.4.2019 | New Publication
28.1.2019 | New Service
We are proud to announce the availability of DigiWest® and RPPA multiplex protein profiling from FFPE samples
25.9.2018 | New Publication
International multisite study of human induced pluripotent stem cell-derived cardiomyocytes for drug proarrhythmic potential assessment
31.5.2018 | CRISPR/Cas9 License
8.11.2017 | New Service
We are pleased to announce the availability of pathway panels for our DigiWest® multiplex immunoassay-based protein profiling services
11.9.2017 | New Product
28.8.2017 | New Offering
We are excited to announce our most recent offering: modified MagPlex® microspheres for Luminex® assays
22.6.2017 | Grant Awarded
NMI TT Pharmaservices and Charité received a grant for protein profiling in individualization of tumor therapy
4.11.2016 | CiPA Core Site
We are very excited that HESI changed our status from non-core to core site for the actual running CiPA myocyte study
26.9.2016 | New Publication
NMI and its CRO NMI TT Pharmaservices announce the publication of their proprietary DigiWest® protein profiling method in Nature Communications
1.8.2016 | Workshop
Come to Reutlingen, and hear about the latest advances in Reverse Phase Protein Arrays (RPPAs) and their application for biomarker research
2.5.2016 | Grant Awarded
Sentinel Oncology and NMI TT Pharmaservices awarded Eurostars grant for development of a novel biomarker for treatment of Fragile X Syndrome (FXS)
9.1.2016 | New Product
Cav1.2 ion channels are expressed in heart, smooth muscle and neurons, and therefore are therapeutic targets in cardiac arrhythmia and hypertension
22.9.2015 | New Branch
NMI TT Pharmaservices today announced that it is growing its operations by establishing a new branch at the Bayer CoLaborator in Berlin
